Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 136–137 (2006)Cite this article

boxed-textStender S et al. (2005) Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes Obes Metab 7: 430–438

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Knopp RH et al. (2003) Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 23: 1437–1443

    Article  CAS  Google Scholar 

  2. Knopp RH (1999) Drug treatment of lipid disorders. N Engl J Med 341: 498–511

    Article  CAS  Google Scholar 

  3. Kasim SE et al. (1992) Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J Lipid Res 33: 1–7

    CAS  PubMed  Google Scholar 

  4. Berk P et al. (2003) Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. Diabetes Care 26: 427–432

    Article  Google Scholar 

  5. Botti RE et al. (1991) Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol 14: 256–261

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by RH Knopp and P Paramsothy. Their work is supported by the NIH Clinical Nutrition Research Unit DK 35816 at the University of Washington and an NIH K-12 award to P Paramsothy (Grant #5K12 HD049100-02).

Author information

Authors and Affiliations

  1. University of Washington School of Medicine,

    Robert H Knopp

  2. Division of Metabolism, Endocrinology and Nutrition at Harborview Medical Center,

    Robert H Knopp

  3. Northwest Lipid Research Clinic, Seattle, WA, USA

    Robert H Knopp

  4. Assistant Professor of Medicine in the University of Washington Department of Cardiology, Seattle, WA, USA

    Pathmaja Paramsothy

Authors
  1. Robert H Knopp
    View author publications

    Search author on:PubMed Google Scholar

  2. Pathmaja Paramsothy
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Robert H Knopp.

Ethics declarations

Competing interests

Dr Knopp has performed clinical trials of lipid-lowering agents sponsored by AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Hoffman-LaRoche, KOS, Sankyo, and Wyeth Pharmaceuticals and has conducted educational seminars sponsored by these manufacturers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knopp, R., Paramsothy, P. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?. Nat Rev Endocrinol 2, 136–137 (2006). https://doi.org/10.1038/ncpendmet0116

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpendmet0116

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing